We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

49 hedge funds and large institutions have $220M invested in Alder Biopharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
+$45.1M
2
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$35M
3
Franklin Resources
Franklin Resources
California
+$11.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.8M
5
PHS
PFM Health Sciences
California
+$10.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$777K +$546K +38,748 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$773K +$542K +38,484 New
Wells Fargo
28
Wells Fargo
California
$769K +$540K +38,323 New
SIM
29
Spark Investment Management
New York
$642K +$452K +32,100 New
Northern Trust
30
Northern Trust
Illinois
$628K +$441K +31,320 New
TCIM
31
TIAA CREF Investment Management
New York
$618K +$434K +30,804 New
PIM
32
Partner Investment Management
California
$560K +$393K +27,893 New
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$372K +$261K +18,528 New
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$293K +$206K +14,600 New
Charles Schwab
35
Charles Schwab
California
$235K +$165K +11,700 New
TA
36
Teachers Advisors
New York
$229K +$161K +11,418 New
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$226K +$158K +11,251 New
Deutsche Bank
38
Deutsche Bank
Germany
$161K +$114K +8,080 New
LTFS
39
Ladenburg Thalmann Financial Services
Florida
$132K +$92.9K +6,600 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$126K +$88.7K +6,300 New
TRCT
41
Tower Research Capital (TRC)
New York
$122K +$85.3K +6,058 New
NFA
42
Nationwide Fund Advisors
Ohio
$122K +$85.6K +6,079 New
AIG
43
American International Group
New York
$105K +$73.7K +5,233 New
BJ
44
BlackRock Japan
Japan
$69K +$48.5K +3,444 New
VFA
45
Virtus Fund Advisers
Connecticut
$14K +$9.6K +682 New
MAA
46
Managed Account Advisors
New Jersey
$9K +$6.38K +453 New
Barclays
47
Barclays
United Kingdom
$4K +$2.48K +176 New
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K +$2.24K +159 New
Citigroup
49
Citigroup
New York
$1K +$957 +68 New
1
2

ALDR Hedge Fund Activity: Q2 2014 in Review

49 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q2 2014, worth a combined $220M.

Buyers outnumbered sellers: 49 funds opened new ALDR positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $45.1M.

  • 49 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q2 2014, up from 0 in Q1 2014.
  • Funds reported $220M of Alder Biopharmaceuticals stock for Q2 2014.
  • 49 funds opened new Alder Biopharmaceuticals positions in Q2 2014 and 0 closed out, a net change of +49 holders.
  • The largest Alder Biopharmaceuticals buyer in Q2 2014 was Novo Holdings A/S, an estimated $45.1M added.

Based on aggregated 13F filings for Q2 2014.